Nikunj Patel Selected Research

durvalumab

1/2021	Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC).
11/2020	Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nikunj Patel Research Topics

Disease

10	Alzheimer Disease (Alzheimer's Disease) 03/2011 - 09/2003
6	Neoplasms (Cancer) 01/2021 - 05/2005
5	Amyloid Plaque 03/2007 - 09/2003
2	Inflammation (Inflammations) 11/2021 - 10/2005
2	Dyspnea (Shortness of Breath) 01/2021 - 11/2020
2	Fatigue 01/2021 - 11/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 02/2022
1	Ischemic Stroke 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	COVID-19 01/2021
1	Chest Pain (Chest Pains) 11/2020
1	Cough 11/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2020
1	Disease Susceptibility (Diathesis) 01/2019
1	Limbal Stem Cell Deficiency 10/2018
1	Myotonic Dystrophy (Dystrophia Myotonica) 07/2017
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2016
1	Hemorrhage 04/2016
1	Back Pain (Backache) 04/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Glossopharyngeal Nerve Diseases (Glossopharyngeal Neuralgia) 01/2015
1	Hypertension (High Blood Pressure) 03/2011
1	Dementia (Dementias) 08/2010
1	Glioma (Gliomas) 08/2010
1	Congenital Abnormalities (Deformity) 04/2009
1	Contracture 04/2009
1	Pathologic Processes 10/2005
1	Gliosis 10/2005
1	Atherosclerosis 05/2005
1	Carcinogenesis 05/2005
1	Leukemia 05/2005
1	Hemorrhagic Stroke 09/2003
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2003

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 01/2011 - 09/2003
6	Amyloid beta-PeptidesIBA 09/2010 - 12/2003
3	Proteins (Proteins, Gene)FDA Link 05/2005 - 09/2003
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2021
2	durvalumabIBA 01/2021 - 11/2020
2	Biological ProductsIBA 01/2019 - 05/2005
1	Pharmaceutical PreparationsIBA 02/2022
1	tremelimumabIBA 01/2021
1	LigandsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Etoposide (VP 16)FDA LinkGeneric 11/2020
1	PlatinumIBA 11/2020
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	AlkaliesIBA 10/2018
1	ibrutinibIBA 04/2016
1	1,4-dihydropyridine (dihydropyridine)IBA 03/2011
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 03/2011
1	matrigelIBA 08/2010
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2010
1	Tamoxifen FDA LinkGeneric 01/2010
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2010
1	Type A Botulinum Toxins (Botox)FDA Link 04/2009
1	Transcription Factors (Transcription Factor)IBA 03/2007
1	NF-kappa B (NF-kB)IBA 03/2007
1	VimentinIBA 10/2006
1	S100 Proteins (S 100 Protein)IBA 10/2006
1	CD40 Ligand (CD40L)IBA 10/2005
1	Amyloid (Amyloid Fibrils)IBA 10/2005
1	Gamma Secretase Inhibitors and ModulatorsIBA 05/2005
1	Peptide Hydrolases (Proteases)FDA Link 05/2005
1	Cadherins (E-Cadherin)IBA 05/2005
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2005

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 05/2022 - 07/2017
1	Therapeutics 07/2017
1	Cholecystectomy 01/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Rhizotomy 01/2015
1	Microvascular Decompression Surgery 01/2015
1	Pancreaticoduodenectomy 11/2014